Tag: global health

Why Investors in the Pharmaceutical Industry Should Start Investing in Diseases Affecting Poor Countries.

Let’s discuss why investors in the pharmaceutical industry should start investing in drugs, therapeutics and medical devices aimed at treating, managing and ameliorating diseases affecting middle income countries in particular and the ‘global south’ in general.

SERIES: Part 5 – Conclusions on Causes and Consequences of Rising Obesity Levels in the UK

I’m back! And this is the fifth and final edition of my ‘Obesity in the UK‘ series: Conclusions on Causes and Consequences of Rising Obesity Levels in the United Kingdom. Throughout this series, we have explored causes and consequences; physiological, behavioral, economic and social. All references are available upon request. So, here’s my sum up: A ...

The Basics: A beginners guide to acronyms and jargon

It’s been a while since I have published a “Basics” series article. I am grateful for the interest I have received on this humble blog of my musings in areas from economic development to novel treatment modes and health policy. Some of the feedback I have received has been concerning my occasionally excessive use of ...

Seven lessons I learned from Professor Hans Rosling: A Tribute

Last week we lost one of the greatest statisticians of our time. A clinician who informed scholars and audiences world over; and a researcher whose work on economic development and global health changed the way we view our world. Personally, too, I have lost a role model, Dr Hans Rosling of the Karolinska Institute. Nonetheless, ...

H

Hans Rosling: A Tribute

He was a clinician and statistician whose research and accessible insights changed the way we view the world, and our understandings of the complex relationships between development and health.

Rethinking Rabies: A Breakthrough in Management? – My comments on the literature

Rabies is a vaccine-preventable, zoonotic disease of global concern, resulting in over 55 000 deaths annually. Whilst standard post-exposure treatments are estimated to prevent hundreds of thousands of fatalities, these are not without shortcomings. Recent immunological research into novel treatments has revealed promising results. Published in the Journal of Infectious Diseases, the research paper this article comments on has been described as groundbreaking. (I dare say, most notably by those enchanted by the spell of the [magical] monoclonal antibody: still one of the coolest cocktail party topics in immunology.)

T

The Basics: Causes of Death

Everyone dies. And on more than a few occasions, I have heard the comments that all, in their own way, suggest that reducing mortality from specific disease causes is merely an exercise in pushing mortality from one disease cause to another; largely based on funding and location.